Global Leader in GLP-Compliant Toxicology Research

TOXINDIA is a GLP-certified and NABL-accredited preclinical Contract Research Organization (CRO) based in Pune, India. We provide regulatory toxicology, environmental safety, and physical-chemical testing services for agrochemicals, industrial chemicals, pharmaceuticals, medical devices, and bioproducts.

Our operations are guided by the OECD Principles of Good Laboratory Practice (GLP) and certified under ISO/IEC 17025:2017, ensuring that every dataset we produce is scientifically sound, reproducible, and globally acceptable across OECD member countries.

With state-of-the-art infrastructure, GLP-compliant animal facilities, and laboratories, TOXINDIA stands as a trusted partner for clients seeking reliable and regulatory-compliant toxicology testing. Our registration with the Central Insecticides Board and Registration Committee (CIB&RC), India further reinforces our role as a recognized authority in agrochemical testing.

We take pride in being more than a CRO — we are a partner in advancing regulatory science, committed to helping industries bring safe, effective, and compliant products to the global market.

Our Leadership Team

Dr. Vasant Narke

Founder & CEO

With over 20 years of experience in toxicology research, Dr. Vasant Narke has built TOXINDIA into a premier GLP-certified facility. His expertise spans all areas of preclinical safety assessment and regulatory toxicology.

Under his leadership, TOXINDIA has completed over 800+ GLP-compliant studies for clients worldwide, helping accelerate product resgistration while maintaining the highest standards of quality and scientific rigor.

Mr. Deven Narke

Managing Partner

With a background in biomedical sciences and experience in consulting and CRO operations, Deven drives strategic growth, international collaborations, and operational excellence at TOXINDIA. His previous roles in translational research and process optimization bring a unique perspective on aligning business growth with scientific rigor.

Dr. Kamlesh Vishwakarma

Technical Director

A chemistry specialist with extensive hands-on experience in OECD guideline studies, Dr. Vishwakarma oversees technical operations and ensures that every study meets stringent GLP and NABL standards. His expertise in method development, study execution, and regulatory submissions provides TOXINDIA with a strong technical backbone.

Dr. Tanvi Visal

Scientific Director

An accomplished translational oncology scientist, Dr. Visal brings her scientific depth to TOXINDIA’s study designs and execution. With experience in molecular biology, preclinical research, and regulatory sciences, she ensures that the scientific rigor of our studies translates into regulatory credibility and client confidence.

Dr. Ujwala Khisti

Technical Director

Dr. Khisti brings nearly three decades of expertise in microbiology and immunology to TOXINDIA. She holds a Ph.D. in Microbiology from the National Chemical Laboratory (NCL), Pune, with a strong foundation in microbial genetics, host–pathogen interactions, and applied immunology. Over her career, she has combined academic rigor with translational research, contributing to advancements that bridge fundamental science with regulatory applications. As Scientific Director at TOXINDIA, Dr. Khisti leverages her deep scientific insight and leadership to strengthen the company’s toxicology research portfolio. With her proven expertise and collaborative approach, she plays a pivotal role in driving innovation and ensuring that TOXINDIA delivers regulator-accepted data and reliable solutions to clients worldwide.

Our Vision

To be a globally trusted partner in regulatory science, advancing toxicological research by:

Delivering reliable and reproducible data for global submissions.
Investing in world-class infrastructure and next-generation technologies.
Upholding integrity, transparency, and ethical responsibility in every study.

Learn More About Us

Our Values

Scientific Integrity: Accuracy, reproducibility, and global compliance at our core.
Collaboration: Strong partnerships with clients and regulators.
Innovation: Upgrading technologies and methods to stay future-ready.
Transparency: Clear, ethical communication and reporting.
Excellence: Setting benchmarks for quality in every study.

Our Commitment

Supporting safe innovation with internationally compliant data.
Enabling faster regulatory approvals through compliance-driven studies.
Maintaining GLP- and NABL-compliant infrastructure for consistent quality.
Investing in people, processes, and technologies to stay ahead of regulatory needs.